HEДокторантска мрежа2027–2031

Implant-to-Market · Initiatives to Accelerate the Translation of Research into Market-Ready Surgical Implantable Medical Devices by Strengthening Regulatory Science and Improved Regulatory Competencies Among Researchers

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период
2027-03-01 → 2031-02-28
Финансиране от ЕС
4 639 196 €
Участници
20
Схема
HORIZON-TMA-MSCA-DN

Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.

Накратко на български

Хирургичните импланти се изследват чрез подобряване на безопасността им и разработване на персонализирани модели с по-малко тестове върху животни. Това помага новите медицински изделия да достигат по-бързо до пазара чрез по-добра връзка между науката, регулациите и индустрията.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Цел на проекта

Implant-to-Market will be a Doctoral Network (combining training and research) composed of 15 academic partners and 5 industrial partners (large companies and SMEs), focused on accelerating the translation of research into market-ready surgical implantable medical devices. Despite major scientific advances, the medical device sector, particularly implantable devices for surgery, still faces slow innovation transfer due to fragmented regulatory knowledge, limited cross-talk between scientists and regulatory experts, and shortages of skilled personnel. Training is therefore essential to reinforce innovation capacity and global competitiveness. A European doctoral network integrating training and research is the most relevant instrument to address these challenges. The training programme developed in this project will be sustained beyond the project, and the qualifications of doctoral candidates and early-career researchers will be established by the consortium using shared methodologies.The research methodology will rely on multidisciplinary and cross-sectoral collaborations involving universities, hospitals and industry. The work packages will address key needs: (i) integrating scientific data into regulatory processes and improving regulatory understanding among researchers; (ii) assessing safety and performance of implantable medical devices; (iii) reducing animal testing through alternative methods; (iv) developing multi-personalized and advanced medical devices; and (v) implementing sustainable-by-design strategies. Expected outcomes include improved regulatory-science practices, enhanced qualification pathways, accelerated translation of innovations, and stronger interaction between research, clinics, regulation and industry. implant-to-market will help bridge the gap between scientific discovery and clinical adoption worldwide.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз